Table 5.
| α-ring | β-ring | |
|---|---|---|
| (1) Actinomycin D as core structure | ||
| Actinomycin D | Thr-D-Val-Pro-Sar-MeVal | Thr-D-Val-Pro-Sar-MeVal |
| (2) N-demethyl actinomycins | ||
| Actinomycin D0 | Thr-D-Val-Pro-Sar-MeVal | Thr-D-Val-Pro-Gly-MeVal |
| N,N′-Didemethyl- actinomycin D | Thr-D-Val-Pro-Gly-MeVal | Thr-D-Val-Pro-Gly-MeVal |
| (2) C-type actinomycins | ||
| Actinomycin C2 | Thr-D-Val-Pro-Sar-MeVal | Thr-D-aIle-Pro-Sar-MeVal |
| Actinomycin C2a | Thr-d-aIle-Pro-Sar-MeVal | Thr-D-Val-Pro-Sar-MeVal |
| Actinomycin C3 | Thr-D-aIle-Pro-Sar-MeVal | Thr-D-aIle-Pro-Sar-MeVal |
| (3) F-type actinomycins | ||
| Actinomycin F8 | Thr-D-Val-Sar-Sar-MeVal | Thr-D-Val-Sar-Sar-MeVal |
| Actinomycin F9 | Thr-D-Val-Sar-Sar-MeVal Thr-D-Val-Pro-Sar-MeVal | Thr-D-Val-Pro-Sar-MeVal Thr-D-Val-Sar-Sar-MeVal |
| (4) X-type actinomycins | ||
| Actinomycin X0α | Thr-D-Val-Sar-Sar-MeVal | Thr-D-Val-Hyp-Sar-MeVal |
| Actinomycin X0β | Thr-D-Val-Pro-Sar-MeVal | Thr-D-Val-Hyp-Sar-MeVal |
| Actinomycin X0δ | Thr-D-Val-Pro-Sar-MeVal | Thr-D-Val-aHyp-Sar-MeVal |
| Actinomycin X1a | Thr-D-Val-Sar-Sar-MeVal | Thr-D-Val-OPro-Sar-MeVal |
| Actinomycin X2 | Thr-D-Val-Pro-Sar-MeVal | Thr-D-Val-OPro-Sar-MeVal |
| (5) Z-type actinomycins | ||
| Actinomycin Z1 | Thr-D-Val-HMPro-Sar-MeVal | HThr-D-Val-MOPro-Sar-MeAla |
| Actinomycin Z2 | Thr-D-Val-HMPro-Sar-MeVal | Thr-D-Val-MOPro-Sar-MeAla |
| Actinomycin Z3 | Thr-D-Val-HMPro-Sar-MeVal | ClThr-D-Val-MOPro-Sar-MeAla |
| Actinomycin Z4 | Thr-D-Val-MPro-Sar-MeVal | Thr-D-Val-MOPro-Sar-MeAla |
| Actinomycin Z5 | Thr-D-Val-MPro-Sar-MeVal | ClThr-D-Val-MOPro-Sar-MeAla |
| Actinomycin Zp | Thr-D-Val-MPro-Sar-MeVal | Thr-D-Val-MPro-Sar-MeVal |
| (6) G-type actinomycins | ||
| Actinomycin G1 | Thr-D-Val-Pro-Sar-MeVal | HThr-D-Val-HMPro-Sar-MeAla |
| Actinomycin G2 | Thr-D-Val-HMPro-Sar-MeVal | ClThr-D-Val-Pro-Sar-MeAla |
| Actinomycin G3 | Thr-D-Val-HMPro-Sar-MeVal | HThr-d-Val-Pro-Sar-MeAla |
| Actinomycin G4 | Thr-D-Val-HMPro-Sar-MeVal | Thr-D-Val-Pro-Sar-MeAla |
| Actinomycin G5 | Thr-D-Val-HMPro-Sar-MeVal | cHThr-D-Val-Pro-Sar-MeAla |
| Actinomycin G6 | Thr-D-Val-HMPro-Sar-MeVal | rHThr-D-Val-Pro-Sar-MeAla |
| (7) novel Y-type actinomycins | ||
| Actinomycin Y1 | Thr-D-Val-HMPro-Sar-MeVal | ClThr-D-Val-OPro-Sar-MeAla |
| Actinomycin Y2 | Thr-D-Val-HMPro-Sar-MeVal | ClThr-D-Val-Hyp-Sar-MeAla |
| Actinomycin Y3 | Thr-D-Val-HMPro-Sar-MeVal | rHThr-D-Val-OPro-Sar-MeAla |
| Actinomycin Y4 | Thr-D-Val-HMPro-Sar-MeVal | rHThr-D-Val-Hyp-Sar-MeAla |
| Actinomycin Y5 | Thr-D-Val-HMPro-Sar-MeVal | cThr-D-Val-OPro-Sar-MeAla |
| Actinomycin Y6 | Thr-D-Val-HMPro-Sar-MeVal | crThr-D-Val-OPro-Sar-MeAla |
| Actinomycin Y7 | Thr-D-Val-HMPro-Sar-MeVal | HThr-D-Val-OPro-Sar-MeAla |
| Actinomycin Y8 | Thr-D-Val-HMPro-Sar-MeVal | Thr-D-Val-OPro-Sar-MeAla |
| Actinomycin Y9 | Thr-D-Val-MPro-Sar-MeVal | Thr-D-Val- OPro -Sar-MeAla |
Differences to actinomycin D are shown in bold letters. All amino acids are L-configuration except when indicated otherwise. Abbreviations: MeVal=N-methylvaline, MeAla=N-methyl-L-alanine, aIle=allo-isoleucine, Sar=sarcosine, MPro=cis-5-methylproline, HMPro=trans-3-hydroxy-cis-5-methylproline, Hyp=trans-4-hydroxyproline, OPro=4- oxoproline, MOPro=cis-5-methyl-4-oxoproline, aHyp=cis-4-hydroxyproline, HThr=4-hydroxythreonine, ClThr=4-chlorothreonine, cThr/cHThr=cyclic Thr or HThr, i.e. forming an additional ring closure to the chromophore, rHThr= rearrangement of the HThr (β-ring) connectivity.
This table was updated based on previous overview on naturally occurring actinomycins (ref. 3).
The numbers in red indicated compounds identified in this study